Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.
Saved in:
| Title: | Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective. |
|---|---|
| Authors: | Reddy MB; Clinical Pharmacology, Oncology, Pfizer Inc., Boulder, Colorado, USA., Cabalu TD; DMPK, Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, New Jersey, USA., de Zwart L; DMPK, Janssen Pharmaceutica NV, A Johnson & Johnson Company, Beerse, Belgium., Ramsden D; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts, USA., Dowty ME; Pharmacokinetics Dynamics and Metabolism, Pfizer Inc, Cambridge, Massachusetts, USA., Taskar KS; DMPK, Pre-Clinical Sciences, Research Technologies, GSK, Stevenage, UK., Badée J; PK Sciences, Biomedical Research, Novartis, Basel, Switzerland., Bolleddula J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA., Boulu L; Modeling and Simulation, Translational Medicine and Early Development, Sanofi, Montpellier, France., Fu Q; Modeling and Simulation, Vertex Pharmaceuticals, Boston, Massachusetts, USA., Kotsuma M; Quantitative Clinical Pharmacology, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Leblanc AF; Quantitative, Translational & ADME Sciences, Development Science, AbbVie, North Chicago, Illinois, USA., Lewis G; DMPK, Pre-Clinical Sciences, Research Technologies, GSK, Stevenage, UK., Liang G; DMPK, Vertex Pharmaceuticals, Boston, Massachusetts, USA., Parrott N; Pharmaceutical Sciences, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Pilla Reddy V; Global PKPD/Pharmacometrics, Eli Lilly and Company, Bracknell, UK and Indianapolis, Indiana, USA., Prakash C; DMPK and Clinical Pharmacology, Agios, Cambridge, Massachusetts, USA., Shah K; Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA., Umehara K; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Mukherjee D; Quantitative Clinical Pharmacology, Daiichi-Sankyo Inc., Basking Ridge, New Jersey, USA., Rehmel J; Global PKPD/Pharmacometrics, Eli Lilly and Company, Bracknell, UK and Indianapolis, Indiana, USA., Hariparsad N; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Feb; Vol. 117 (2), pp. 403-420. Date of Electronic Publication: 2024 Oct 18. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.3477 |
